Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.152.313.244.014.89

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.15 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.15
Mar20232.31
Mar20223.24
Mar20214.01
Mar20204.89

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01
-18.00
Mar2020 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹424.6 Cr 6.5% 2.1% -21.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,544.0 Cr 2.7% -2.4% 49.5% Stock Analytics
DIVIS LABORATORIES ₹164,865.0 Cr 2.9% 6.2% 64.2% Stock Analytics
CIPLA ₹123,920.0 Cr 1% 6.4% 28.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,224.0 Cr 1% -2.3% 6% Stock Analytics
ZYDUS LIFESCIENCES ₹98,832.3 Cr 2.4% -1.1% 53.4% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

6.5%

2.1%

-21.1%

SENSEX

1.1%

1.1%

22.2%


You may also like the below Video Courses